Skip to main content

Advertisement

Log in

Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia

  • Original Articles
  • Vincristine and Prednimustine ANLL in Elderly Patients Ara-C-6-TG
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Sixty-seven patients with acute nonlymphoblastic leukemia (ANLL) and above the age of 60 years were randomly allocated to treatment with either prednimustine+vincristine or cycles with cytosine arabinoside and thioguanine. Of the 67 patients, 13 (19%) entered a complete remission and four a partial remission. Of 33 patients randomized to prednimustine and vincristine (15 adequately treated), three entered a complete remission and one a partial remission. Four further patients went into complete remission after a switch to other treatment modalities. Of 34 patients randomized to cycles of ARA-C and thioguanine (22 adequately treated), four entered a complete remission and three a partial remission with the correct program. One patient entered a remission with intermittent cytosine arabinoside+thioguanine (wrong program) and one further patient entered a complete remission after a switch to prednimustine and vincristine. Prednimustine+vincristine did not appear to be superior to treatment with cytosine arabinoside thioguanine cycles for elderly patients with ANLL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bodey GP, Coltman CA, Freireich EJ, et al. (1974) Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. Arch Intern Med 133:260

    Google Scholar 

  2. Brandt L, Könyves I (1977) Therapeutic effect of prednimustine (Leo 1031) in various types of leukaemia. Eur J Cancer 13:393

    Google Scholar 

  3. Brandt L, Könyves I (1979) Prednimustine in adult acute leukaemia. Cancer Chemother Pharmacol 2:133

    Google Scholar 

  4. Brandt L, Könyves I, Möller TR (1975) Therapeutic effect of Leo 1031, an alkylating corticosteroid ester in lymphoproliferative disorders. I. Chronic lymphocytic leukaemia. Acta Med Scand 197:317

    Google Scholar 

  5. Burge PS, Richards JDM, Thompson DS, et al. (1975) Quality and quantity of survival in acute myeloid leukaemia. Cancer 2:621

    Google Scholar 

  6. Crabtree GR, Smith KA, Munck A (1978) Glucocorticoid receptors and sensitivity of isolated human leukemia and lymphoma cells. Cancer Res 38:4268

    Google Scholar 

  7. Crosby WH (1968) To treat or not to treat granulocytic leukemia. Arch Intern Med 122:79

    Google Scholar 

  8. Crosby WH (1974) Grounds for optimism in treating acute granulocytic leukemia. Arch Intern Med 134:177

    Google Scholar 

  9. Crosby WH (1976) Acute granulocytic leukemia (AGL) in the elderly. Arch Intern Med 136:493

    Google Scholar 

  10. Evenaar AH, Wins EHR, Van Putten LM (1973) Cell killing effectiveness of an alkylating steroid (Leo 1031). Eur J Cancer 9:773

    Google Scholar 

  11. Guyer RJ, Winfield DA, Shahani RT, Blackburn EK (1971) Combination chemotherapy in acute myeloblastic leukemia. Br Med J 1:231

    Google Scholar 

  12. Håkansson L, Könyves I, Lindberg LG, Möller T (1978) Continuous treatment of non-Hodgkin's malignant lymphoma with Prednimustine (Leo 1031). Oncology 35:103

    Google Scholar 

  13. Hansson L-A, Gustafsson SA, Carlstedt-Duke J, Gahrton G, Högberg B, Gustafsson J-Å (1982) Glucocorticoid receptor content in leukemia cells. (in manus)

  14. Ho AD, Hunstein W, Schmid W (1981) Glucocorticoid receptors and sensitivity in leukemias. Blut 42:183

    Google Scholar 

  15. Jensen HS, Hansen HH, Dombernowsky P (1980) Phase II trial of Prednimustine (NSC-124087) in the treatment of small-cell anaplastic carcinoma of the lung. Cancer Chemother Pharmacol 4:259

    Google Scholar 

  16. Juul K, Sørensen P, Pedersen-Bjergaard J, Krogh-Jensen M (1979) Phase II trial of Prednimustine, Leo-1031 (NSC-134087) in acute non-lymphocytic leukaemia. Scand J Haematol 23:388

    Google Scholar 

  17. Kontula K, Andersson LC, Paavonen T, Myllylä G, Teerenhovi L, Vuopio P (1980) Glucocorticoid receptors and glucocorticoid sensitivity of human leukemic cells. Int J Cancer 26:177

    Google Scholar 

  18. Könyves I, Liljekvist J (1976) The steroid molecule as a carrier of cytotoxic groups. Excerpta Medica, Amsterdam, p 98 (Int Congress Series no. 375)

    Google Scholar 

  19. Könyves I, Fex H, Högberg B (1974) Novel corticosteroid esters with alkylkating properties. In: Daikos GK (ed) Antineoplastic chemotherapy, vol III. Proc 8th Congr Chemotherapy, Athens, p 791

  20. Lippman ME, Perry S, Thompson EB (1975) Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia. Am J Med 59:224

    Google Scholar 

  21. Mandelli F, Amadori S, Fabiani F, Grignani F, Liso V, Martelli M, Neri A, Petti MC, Tonato M (1979) Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicenter study. Haematologica 64:331

    Google Scholar 

  22. Mattsson W, von Eyben F, Turesson I, Wahlby S (1978) Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histocytic lymphomas. Cancer 41:112

    Google Scholar 

  23. Medical Research Council's Working Party on leukaemia in Adults (1974) Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine,l-asparaginase, prednisone and thioguanine—Results of treatment with five multiple-drug schedules. Br J Haematol 27:373

    Google Scholar 

  24. Möller TR, Brandt L, Könyves I, Lindberg LG (1975) Therapeutic effect of Leo 1031, an alkylating corticosteroid ester in lymphoproliferative disorders. II. Lymphocytic lymphoma. Acta Med Scand 197:323

    Google Scholar 

  25. Mouridsen HT, Kristensen D, Halskov-Nielsen J, Dombernowsky P (1980) Phase II trial of Prednimustine, L-1031 (NSC-134087) in advanced breast cancer. Cancer 46:253

    Google Scholar 

  26. Pedersen-Bjergaard J, Mørk-Hansen M, Geisler CM, Nissen NI (1980) Clinical trial of Prednimustine, Leo 1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroid and alkylating agents. Acta Med Scand 207:215

    Google Scholar 

  27. Petersen BA, Bloomfield CD (1977) Treatment of acute nonlymphocytic leukemia in elderly patients. A prospective study of intensive chemotherapy. Cancer 40:647

    Google Scholar 

  28. Rubio LF Jr (19609) Acute leukemia in patients past the age of 50. J Am Geriatr Soc 8:644

    Google Scholar 

  29. Udén A-M, Brenning G, Engstedt L, et al. (1975)l-Asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia. Scand J Haematol 15:72

    Google Scholar 

  30. Wiernik PH, Serpick AA (1970) Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL). Medicine (Baltimore) 49:505

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lönnqvist, B., Andersson, B., Björkholm, M. et al. Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. Cancer Chemother. Pharmacol. 9, 89–92 (1982). https://doi.org/10.1007/BF00265385

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00265385

Keywords

Navigation